ARCHIVES

Conferees Set NIH Funding At $30 Billion.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

In Brief: Komen Foundation Awards Honor Gingell, Osborne, Freeman; Tobacco Regulation Urged

October 21, 1994

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

Gottlieb questions ODAC’s independence.

August 5, 2005

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006